<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2304245198
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2000
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MONOZIDE 12.5MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HYDROCHLOROTHIAZIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        12.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        8.4
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1055]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Dallah Health Care Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C03AA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The name of your medicine is MONOZIDE. The active ingredient of MONOZIDE is Hydrochlorothiazide. This belongs to a class of medicines known as &quot;Thiazide Diuretic&quot;. MONOZIDE helps prevent your body from absorbing too much salt, which can cause fluid retention so lowers blood pressure and gets rid of extra salt and water in the body. This medicine used: □ To treat Fluid retention (edema) in people with congestive heart failure, cirrhosis of the liver or kidney disorders or edema caused by taking steroids or estrogen. □ To treat high blood pressure (hypertension)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take MONOZIDE: □ If you have anuria that means inability to urinate. □ Hypersensitivity to Hydrochlorothiazide or to other sulfonamide-derived drugs. If any of the above apply to you, do not take MONOZIDE. Take special care with MONOZIDE: □ If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. □ If you have liver disease □ If you have Kidney disease □ If you have glaucoma □ If you have conditions that may cause very low blood pressure include: vomiting, diarrhea, heavy sweating, heart disease, dialysis, a low salt diet. □ If you older adults may be more sensitive to the effects of this drug, especially dizziness □ If you have gout □ If you are breast-feeding □ If you are Pregnant □ You may get sunburned more easily. Avoid sun, sunlamps and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun. □ If you experience a decrease in vision or eye pain. These could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase of pressure in your eye and can happen within hours to weeks of taking MONOZIDE. This can lead to permanent vision loss, if not treated. If you earlier have had a penicillin or sulfonamide allergy, you can be at higher risk of developing this. If any of the above apply to you, tell your doctor before you take MONOZIDE. Taking other medicines with MONOZIDE: Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. The effect of the treatment can be influenced if MONOZIDE is taken together with certain other medicines. It may be necessary to change the dose, to take other precautions or in some cases to stop taking one of the medicines. This applies to both prescription and non-prescription medicines, especially: □ Lithium □ Digoxin □ Cholestyramine □ Steroids (prednisone and others) □ Other blood pressure medications □ NSAID (non-steroidal anti-inflammatory drugs) such as aspirin, ibuprofen, naproxen, celecoxib, diclofenac, meloxicam and others □ Insulin or oral diabetes medication This medication may interfere with certain laboratory tests (including parathyroid function), possibly causing false test results. Make sure laboratory personnel and all your doctors know you use this drug. Taking MONOZIDE with food and drink: Take with or without food. Take with food if it causes an upset stomach. May be administered with milk. MONOZIDE may decrease your potassium levels. Ask your doctor about foods high in potassium (such as bananas, orange juice) or about using a salt substitute containing potassium. Pregnancy and breast feeding: Pregnancy During pregnancy, MONOZIDE should be used only when clearly needed. Discuss the risks and benefits with your doctor. Breast-feeding MONOZIDE passes into breast milk, but is unlikely to harm a nursing infant. Consult your doctor before breast-feeding. Driving and using machines: This drug may make you dizzy. Do not drive, use machinery or do any activity that requires alertness until you are sure you can perform such activities safely. Important information about some of the ingredients of MONOZIDE: This medicine contains lactose (a type of sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take MONOZIDE exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. It is important to keep taking MONOZIDE every day. You can take MONOZIDE with or without food. Swallow the tablet with a drink of water. Take MONOZIDE early in the day, it is best to avoid taking this medication within 4 hours of your bedtime to prevent having to get up to urinate. Try to take the tablet at the same time each day. This will help you to remember to take it. Adults: □ For Edema: The usual adult dosage is 25 mg to 100 mg daily as a single or divided dose. □ For Control of Hypertension: The usual initial dose in adults is 25 mg daily given as a single dose. The dose may be increased to 50 mg daily, given as a single or two divided doses. Infants and Children: □ For Diuresis and For Control of Hypertension: The usual pediatric dosage is 0.5 mg to 1 mg per pound (1 to 2 mg/kg) per day in single or two divided doses, not to exceed 37.5 mg per day in infants up to 2 years of age or 100 mg per day in children 2 to 12 years of age. In infants less than 6 months of age, doses up to 1.5 mg per pound (3 mg/kg) per day in two divided doses may be required. If you take more MONOZIDE than you should: Overdose symptoms may include nausea, weakness, dizziness, dry mouth, thirst, and muscle pain or weakness. Seek emergency medical attention if you experience severe dizziness and/or fainting, contact your doctor immediately and lie down. If you have accidentally taken too many tablets then contact your doctor, pharmacist or hospital. If you forget to take MONOZIDE : If you forget to take a dose then take it as soon as you remember. However, if it is almost time for your next dose, skip the dose you missed. Do not take a double dose to make up for a forgotten dose. If you stop taking MONOZIDE : Stopping your treatment with MONOZIDE may cause your disease to get worse. Do not stop taking your medicine unless your doctor tells you to. If you have any further questions on the use of this product, ask your doctor or pharmacist</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, MONOZIDE can cause side effects, although not everybody gets them. Some symptoms need emergency medical help: If you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue or throat. If you get any of these, see your doctor immediatelyStop using this medication and call your doctor at once if you have a serious side effect such as: □ Eye pain, vision problems □ Dry mouth, thirst, nausea, vomiting □ Feeling weak, drowsy, restless or light-headed □ Fast or uneven heartbeat □ Muscle pain or weakness □ Numbness or tingly feeling □ A red, blistering, peeling skin rash □ Nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes) Less serious side effects may include: □ Diarrhea □ Mild stomach pain □ Constipation □ Blurred vision. Unknown frequency side effects: □ Decrease in vision or pain in your eyes due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma). □ Non-melanoma Skin Cancer: Hydrochlorothiazide is associated with an increased risk of non-melanoma skin cancer. If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>□ Keep out of the reach and sight of children. □ Do not store above 30 &deg;C. □ Do not use MONOZIDE after the expiry date which is stated on the carton and on the blister, after (EXP).Date. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What MONOZIDE contains: □ The active substance is Hydrochlorothiazide. Each tablet of MONOZIDE 12.5 and 25 contains Hydrochlorothiazide 12.5 and 25 mg, respectively. □ The other ingredients are: lactose DC, pregelatinized maize Starch, colloidal Anhydrous Silica, purified talc, magnesium Stearate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                □ MONOZIDE 12.5 mg tablets are off- white circular flat face bevelled edge tablet debossed with “MO 
12.5” on one side and plain on the other side.
□ MONOZIDE 25 mg Tablets are off white circular flat face bevelled edge Tablet debossed with “MO 
25” on one side and scored on the other side.
□ Boxes of 30 blistered tablets of MONOZIDE 12.5.
□ Boxes of 1000 blistered tablets of MONOZIDE 12.5.
□ Boxes of 30 blistered tablets of MONOZIDE 25.
□ Boxes of 1000 blistered tablets of MONOZIDE 25
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Jordanian pharmaceutical manufacturing company. P.O. BOX 151, Um Al-Amad 16197, Jordan Saudi Arabia: To report any side effect(s): National Pharmacovigilance Center (NPC): Fax: +966-11-205-7662, SFDA Call center: 19999, E-mail: npc.drug@sfda.gov.sa, Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Sebtember 2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>مونوزاید ھو اسم دوائك الذي یحتوي على المادة الفعالة ھیدروكلوروثیازاید، وھو ینتمي إلى مجموعة من الأدویة تدعى مدرات ثیازیدیة. و ھو یقلل من امتصاص الأملاح التي تسبب استرجاع السوائل للجسم و ینتج من ذلك تقلیل الضغط و التخلص من السوائل الزائدة في الجسم. یستخدم ھذا الدواء: □ لـعلاج السوائل الزائدة الناتجة من فشل القلب الاحتقاني، تشمع الكبد، أمراض الكلى والودمة الناتجة من تناول الإستروجین. □ لـعلاج ارتفاع ضغط الدم</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تتناول مونوزاید: □ إذا كنت تعاني من عدم القدرة على التبول. □ إذا كنت تعاني من حساسیة للھیدروكلورثیازاید أو أي مشتق آخر من مشتقات السلفا. الاحتیاطات عند استعمال مونوزاید : □ إذا كنت تعاني من ارتفاع السكر في الدم (مرض السكري)، حیث أن ھذا الدواء یؤدي إلى رفع نسبة السكر في الدم □ إذا كنت تعاني من أمراض في الكبد □ إذا كنت تعاني من الزرق (جلوكوما) □ إذا كنت تعاني من أمراض وخیمة في الكلى أو إذا كنت تخضع لدیال (غسیل) كلوي. □ إذا كنت تعاني من حالات تؤدي إلى انخفاض ضغط الدم لدیك مثل: التقیؤ، الإسھال،التعرق الشدید، أمراض القلب، دیال (غسیل) كلوي، الطعام قلیل الملح □ إذا كنت كبیر في السن فإن احتمال حصول الأعراض الجانیة أكثر و خاصة الدوخة ً □ إذا كنت مرضعة □ إذا كنت تعاني من النقرس □ إذا كنت حاملا □ قد تزداد إمكانیة احتراق بشرتك عند التعرض لأشعة الشمس، لذلك یجب علیك أن تتجنب أشعة الشمس وعملیات دباغة الجلد واستعمال واقي أشعة الشمس والنظارات والملابس التي تحمي بشرتك من الحرق. □ إذا كنت تعاني من انخفاض في الرؤیة أو ألم في العین. یمكن أن تكون ھذه أعراض تجمع السوائل في الطبقة الوعائیة للعین (انصباب المشیمیة) أو زیادة الضغط في عینك ویمكن أن یحدث في غضون ساعات إلى أسابیع من تناول مونوزاید. یمكن أن یؤدي ذلك إلى فقدان الرؤیة الدائم ، إذا لم یتم علاجھ. إذا كان لدیك في وقت سابق حساسیة من البنسلین أو السلفونامید، فقد تكون أكثر عرضة للإصابة بھذا. علیك إخبار طبیبك قبل تناول مونوزاید أو أثناء تناولھ إذا انطبق علیك أي من المذكور أعلاه. تناول أدویة أخرى مع مونوزاید: ً أي أدویة أخرى، بما في ذلك الأدویة التي تم الحصول علیھا أخبر طبیبك أو الصیدلاني إذا كنت تستخدم أواستخدمت موخرا دون وصفة طبیة. یمكن أن تتأثر فعالیة العلاج إذا تم أخذ مونوزاید مع أدویة معینة، قد یكون من الضروري تغییر الجرعة أو أخذ احتیاطات معینة أو في بعض الحالات التوقف عن تناول إحدى ھذه الأدویة. و ھذا ینطبق على الأدویة التي تؤخذ بوصفة طبیة أو بدون و :ً خصوصا □ اللیثیوم □ الدیجوكسین □ الكولسترامین □ الستیرویدات (بریدنیزون وغیرھا) □ الأدویة الأخرى التي تستخدم لعلاج ضغط الدم □ مضادات الالتھاب غیر الستیرویدیة مثل الأسبرین، أیبوبروفین، نابروكسین، السیلیكوكسیب، دیكلوفیناك، میلوكسیكام وغیرھا □ الأنسولین أو أدویة السكري التي تؤخذ عن طریق الفمقد یتداخل ھذا الدواء مع بعض الفحوصات المخبریة (بما في ذلك وظیفة الغدة الدرقیة)، وربما یؤدي إلى نتائج فحوصات خاطئة. لذلك علیك إخبار الطبیب ومحلل المختبر أنك تستخدم ھذا الدواء. تناول مونوزاید مع الطعام والمشروبات : یمكن تناول مونوزاید مع أو بدون الطعام. تناولھ مع الطعام إذا تسبب لك في اضطراب في المعدة. و یمكن تناولھ مع الحلیب. قد یؤدي مونوزاید إلى خفض مستوى البوتاسیوم لدیك. اسأل طبیبك عن الأطعمة الغنیة بالبوتاسیوم (مثل الموز وعصیر البرتقال) أو استخدام الأملاح الغنیة بالبوتاسیوم. الحمل والإرضاع: الحمل أثناء الحمل یستخدم مونوزاید فقط عند الحاجة الشدیدة لھ. لذا یجب مناقشة استخدام الدواء خلال الحمل مع الطبیب. الإرضاع ً ما یسبب ضرر أخبري طبیبك إذا كنت مرضعة أو على وشك البدء بالإرضاع لأن مونوزاید یخرج في الحلیب لكن نادرا للرضیع. لذا یجب مناقشة استخدام الدواء خلال الرضاعة مع الطبیب. قیادة السیارات واستعمال الآلات : بعض الناس قد یشعرون بالتعب والدوار عند تناول مونوزاید. إذا حدث لك ذلك، فلا تقود أو تستخدم أي أداة أو ألة حتى تتأكد من أنك قادر على عمل ھذه الأعمال بتركیز و یقظة. معلومات ھامة عن بعض مكونات مونوزاید: یحتوي ھذا الدواء على اللاكتوز (وھو نوع من السكر). إذا قیل لك من قبل الطبیب أن لدیك عدم القدرة على تحمل بعض السكریات، اتصل بطبیبك قبلتناول ھذا الدواء</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>۳ طریقة استخدام مونوزاید ً تناول مونوزاید بالضبط كما أخبرك طبیبك. یجب علیك التحقق من طبیبك أو الصیدلاني إذا كنت غیر متأكد من طریقة دائما استخدامھ. من المھم تتناول مونوزاید كل یوم. من الممكن تناول مونوزاید مع أو بدون الطعام. ابتلع القرص مع الماء. تناول مونوزاید في الصباح ویفضل أخذ مونوزاید قبل أربع ساعات على الأقل من النوم حتى تتفادى الاستیقاظ من النوم للذھاب للحمام. حاول تناول القرص في نفس الوقت كل یوم. فإن ھذا سیساعدك على تذكر تناول الدواء. البالغین: □ لعلاج الوذمة: ً كجرعة واحدة أو مقسم خلال الیوم. الجرعة الاعتیادیة للبالغین ھي ۲٥ ملغم إلى ۱۰۰ ملغم یومیا □ للسیطرة على ارتفاع الضغط: ً تعطى كجرعة واحدة جرعة البدء الاعتیادیة للبالغین ھي ۲٥ ملغم تعطى مرة واحدة. ویمكن زیادة الجرعة الى ٥۰ ملغم یومیا أو كجرعتین منفصلتین. الأطفال والرضع: □ لإدرار البول و للسیطرة على ارتفاع الضغط: الجرعة الاعتیادیة للأطفال ھي ۰٫٥ ۱- ملغم لكل بوند (۲-۱ ملغم لكل كغم) بالیوم تعطى كجرعة واحدة أو كجرعتین منفصلتین ویجب أن لا تتجاوزالجرعة ۳۷٫٥ ملغم بالیوم للأطفال الرضع الذین لم یتجاوزوا السنتین من عمرھم. أو أن لا تزید الجرعة عن ۱۰۰ملغم بالیوم للأطفال الذین تتراوح أعمارھم بین ۱۲-۲ سنة. في الأطفال الرضع الذین عمرھم أقل من ٦ شھور فقد یحتاجون إلى جرعة قد تصل إلى ۱٫٥ملغم لكل بوند (۳ملغم لكل كغم) في الیوم مقسمة على جرعتین. إذا تناولت مونوزاید أكثر مما یجب : أعراض تناول جرعة زائدة ھي: الشعور بالغثیان، الضعف، الدوار، جفاف الفم، العطش و ألم في العضلات. .ً إذا واجھت دوار شدید و/أو الإغماء، علیك الاستلقاء و الاتصال بالطبیب فورا إذا تناولت مونوزاید أكثر مما وصفھ لك طبیبك، علیك الاتصال بالطبیب أو الصیدلاني مباشرة للحصول على المشورة والاسعاف الفوري اللازم. إذا نسیت تناول مونوزاید: إذا نسیت تناول جرعة فإنھ یجب علیك تناولھا حال تذكرھا، اذا اقترب موعد الجرعة التالیة فلا تتناول الجرعة المنسیة. لا تضاعف الجرعة الثانیة لتعویض الجرعة المنسیة. إذا توقفت عن تناول مونوزاید: إذا توقفت عن تناول مونوزاید، فإن مرضك قد یصبح أسوأ. لذلك لاتوقف تناول مونوزاید دون استشارة طبیبك. إذا كان لدیك أي أسئلة أخرى حول استخدام مونوزاید، اسأل طبیبك أو الصیدلاني</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>بالرغم من أنھا لاتحدث للجمیع. ً جانبیة كغیره من الأدویة، فقد یسبب مونوزاید آثارا بعض الأعراض تحتاج إلى عنایة طبیة فوریةأعراض التفاعل التحسسي مثل: شرى ،صعوبة في التنفس، انتفاخ الوجھ أو الشفاه أو اللسان أو الحلق في التنفس أو البلع، شرى أو حكة. إذا لاحظت أي من ھذه الأعراض فإن علیك مراجعة طبیبك على الفور. توقف عن تناول الدواء وأبلغ طبیبك المسؤول إذا ظھرت علیك أي من ھذه الأعراض الجانبیة الخطیرة: □ ألم في العینین و مشاكل في الرؤیة □ جفاف في الفم، عطش، غثیان، و تقيء □ الشعور بالضعف و الدوران و الصداع □ تسارع أو عدم انتظام في نبضات القلب □ ألم في العضلات و ضعف فیھا □ التنمل والشعور بالوخز □ ظھور تقرحات حمراء متقشرة على الجلد □ غثیان، ألم في أعلى المعدة، حكة، فقدان للشھیة، بول داكن، خروج براز طیني اللون، الیرقان (اصفرار الجلد والعینین) أثار جانبیة أقل خطورة: □ إسھال □ ألم معدة خفیف □ إمساك □ رؤیة غیر واضح آثار جانبیة غیر معروفة التكرار: □ انخفاض في الرؤیة أو ألم في عینیك بسبب ارتفاع الضغط (علامات محتملة لتراكم السوائل في الطبقة الوعائیة للعین (انصباب المشیمیة) أو زرق (جلوكوما) حاد مغلق الزاویة (من أنواع ارتفاع ضغط العین). □ سرطان الجلد غیر المیلانیني: یرتبط ھیدروكلوروثیازاید بزیادة خطر الإصابة بسرطان الجلد غیر المیلانیني. إذا حدث أي من ھذه الأعراض الجانبیة بشدة، أو إذا لاحظت أي آثار جانبیة غیر المدرجة في ھذه النشرة، یرجى إخبار الطبیب أو الصیدلاني</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>عن متناول الأطفال. □ یحفظ بعیدا □ لا یحفظ بدرجة حرارة أعلى من &deg;۳۰م. □ لا ینبغي استعمال مونوزاید بعد تاریخ انتھاء الصلاحیة الموجود على العلبة وعلى شریط الدواء. لا ینبغي التخلص من الأدویة من خلال میاه الصرف الصحي أو المنزلي. اسأل الصیدلاني عن كیفیة التخلص من الأدویة التي لم تعد مطلوبة. سوف تساعد ھذه الاجراءات على حمایة البیئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>على ماذا یحتوي مونوزاید: □ المادة الفعالة ھي ھیدروكلوروثیازاید. كل قرص من أقراص مونوزاید ۱۲٫٥و ۲٥ یحتوي على ۱۲٫٥ و۲٥ ملغم من ھیدروكلوروثیازاید، على التوالي. □ المكونات الأخرى ھي : لاكتوز DC، نشا الذرة، سیلیكاغرویة لامائیة، تلك منقى، ستیارات المغنیزیوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>□ أقراص مونوزاید ۱۲٫٥ ملغم ھي أقراص سكریة اللون مسطحة مائلة الأطراف منقوش علیھا &ldquo;12.5 MO &ldquo;من جانب واحد وغیر منقوش علیھا من الجانب الآخر. □ أقراص مونوزاید ۲٥ ملغم ھي أقراص سكریة اللون مسطحة مائلة الأطراف منقوش علیھا &ldquo;25 MO &ldquo;من جانب واحد ومحززة من الجانب الآخر. □ علب تحتوي على ۳۰ قرص من أقراص مونوزاید ۱۲٫٥ المحفوظة في أشرطة. □ علب تحتوي على ۱۰۰۰ قرص من أقراص مونوزاید ۱۲٫٥ المحفوظة في أشرطة □ علب تحتوي على ۳۰ قرص من أقراص مونوزاید ۲٥ المحفوظة في أشرطة. □ علب تحتوي على ۱۰۰۰ قرص من أقراص مونوزاید ۲٥ المحفوظة في أشرطة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة الأردنیة لإنتاج الأدویة. ص.ب. -۱٥۱ أم العمد ۱٦۱۹۷ - الأردن. المملكة العربیة السعودیة: للإبلاغ عن الأعراض الجانبیة: المركزالوطني للتیقظ: فاكس: ،۰۰۹٦٦۱۱۲۰٥۷٦٦۲ مركز اتصال الھیئة العامة للغذاء والدواء (SFDA(،۱۹۹۹۹: البرید الإلكتروني: sa.gov.sfda@drug.npc، https://ade.sfda.gov.sa :الإلكتروني ا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أیلول ۲
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MONOZIDE 12.5 mg Tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active Ingredient:

Each tablet contains Hydrochlorothiazide 12.5 mg.

Inactive Ingredients:

Ingredient	Quantity
mg/tab.
Lactose Direct Compression (Ludipress)	58.06
Pregelatinized maize starch 	7.62
Purified Talc	0.8
Colloidal anhydrous silica	0.16
Magnesium stearate	0.8

*For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MONOZIDE 12.5 Tablet:
Off- white circular, flat face bevelled edge tablet debossed with “MO 12.5” on one side and plain on the other side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>R</strong><strong>oute of administration</strong>: Oral</p><p>&nbsp;</p><p>Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response.</p><p>&nbsp;</p><p><strong>Adults</strong></p><p>&nbsp;</p><p><u>For</u><u> </u><u>Edema:</u></p><p>&nbsp;</p><p>The usual adult dosage is 25 mg to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on 3 to 5 days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely to occur.</p><p>&nbsp;</p><p><u>F</u><u>or Control of Hypertension:</u></p><p>&nbsp;</p><p>The usual initial dose in adults is 25 mg daily given as a single dose. The dose may be increased to 50 mg daily, given as a single or two divided doses. Doses above 50 mg are often associated with marked reductions in serum potassium (see also section 4-4).</p><p>Patients usually do not require doses in excess of 50 mg of Hydrochlorothiazide daily when used concomitantly with other antihypertensive agents.</p><p>&nbsp;</p><p><strong>Infants and Children</strong></p><p>&nbsp;</p><p><u>F</u><u>or Diuresis and For Control of Hypertension:</u></p><p>&nbsp;</p><p>The usual pediatric dosage is 0.5 mg to 1 mg per pound (1 to 2 mg/kg) per day in single or two divided doses, not to exceed 37.5 mg per day in infants up to 2 years of age or 100 mg per day in children 2 to 12 years of age. In infants less than 6 months of age, doses up to 1.5 mg per pound (3 mg/kg) per day in two divided doses may be required.</p><p>&nbsp;</p><p>May be administered with food or milk.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •   Anuria.

•   Hypersensitivity to this product or to other sulfonamide-derived drugs.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p><strong>Warnings</strong></p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Use with caution in severe renal disease. In patients with renal disease, Hydrochlorothiazide may precipitate azotemia. Cumulative effects of the drug may develop in patients with impaired renal function.</p><p>&bull;&nbsp;&nbsp;&nbsp; Hydrochlorothiazide should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma.</p><p>&bull;&nbsp;&nbsp;&nbsp; Hydrochlorothiazide may add to or potentiate the action of other antihypertensive drugs.</p><p>&bull;&nbsp;&nbsp;&nbsp; Sensitivity reactions may occur in patients with or without a history of allergy or bronchial asthma.</p><p>&bull;&nbsp;&nbsp;&nbsp; The possibility of exacerbation or activation of systemic lupus erythematosus has been reported.</p><p>&bull;&nbsp; &nbsp;Lithium generally should not be given with diuretics (see section 4-5).</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Choroidal effusion, acute myopia and secondary angle-closure glaucoma:</p><p>Sulfonamide or sulfonamide derivative drugs can cause an idiosyncratic reaction resulting in choroidal effusion with visual field defect, transient myopia and acute angle-closure glaucoma. Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation. Untreated acute angle-closure glaucoma can lead to permanent vision loss. The primary treatment is to discontinue drug intake as rapidly as possible. Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled. Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy</p><p>&nbsp;</p><p><strong>P</strong><strong>recautions</strong></p><p>&nbsp;</p><p><strong>G</strong><strong>e</strong><strong>ne</strong><strong>ral</strong></p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; All patients receiving diuretic therapy should be observed for evidence of fluid or electrolyte imbalance: namely, hyponatremia, hypochloremic alkalosis, and hypokalemia. Serum and urine electrolyte determinations are particularly important when the patient is vomiting excessively or receiving parenteral fluids. Warning signs or symptoms of fluid and electrolyte imbalance, irrespective of cause, include dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, confusion, seizures, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances such as nausea and vomiting.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Hypokalemia may develop, especially with brisk diuresis, when severe cirrhosis is present or after prolonged therapy.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Interference with adequate oral electrolyte intake will also contribute to hypokalemia. Hypokalemia may cause cardiac arrhythmia and may also sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). Hypokalemia may be avoided or treated by use</p><p>of potassium sparing diuretics or potassium supplements such as foods with a high potassium content.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Although any chloride deficit is generally mild and usually does not require specific treatment except under extraordinary circumstances (as in liver disease or renal disease), chloride replacement may be required in the treatment of metabolic alkalosis.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Dilutional hyponatremia may occur in edematous patients in hot weather; appropriate therapy is water restriction, rather than administration of salt, except in rare instances when the hyponatremia is life threatening. In actual salt depletion, appropriate replacement is the therapy of choice.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Hyperuricemia may occur or acute gout may be precipitated in certain patients receiving Hydrochlorothiazide.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; In diabetic patient&rsquo;s dosage adjustments of insulin or oral hypoglycemic agents may be required. Hyperglycemia may occur with thiazide diuretics. Thus latent diabetes mellitus may become manifest during thiazide therapy.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; The antihypertensive effects of the drug may be enhanced in thepost- sympathectomy patient.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; If progressive renal impairment becomes evident, consider withholding or discontinuing diuretic therapy.</p><p>&bull;&nbsp;&nbsp;&nbsp; Hydrochlorothiazide have been shown to increase the urinary excretion of magnesium; this may result in hypomagnesemia.</p><p>&bull;&nbsp; &nbsp;Hydrochlorothiazide may decrease urinary calcium excretion.</p><p>Hydrochlorothiazide may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. Marked hypercalcemia may be evidence of hidden hyperparathyroidism. Hydrochlorothiazide should be discontinued before carrying out tests for parathyroid function.</p><p>&bull;&nbsp;&nbsp;&nbsp; Increases in cholesterol and triglyceride levels may be associated with thiazide diuretic therapy.</p><p>&nbsp;</p><p><strong>L</strong><strong>aboratory Tests</strong></p><p>Periodic determination of serum electrolytes to detect possible electrolyte</p><p>imbalance should be done at appropriate intervals.</p><p>&nbsp;</p><p><strong><u>Excipients</u></strong></p><p>This medicinal product contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>W</u><u>hen given concurrently the following drugs may interact with thiazide diuretics:</u></p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; <strong>Alcohol, barbiturates, or narcotics </strong>potentiation of orthostatic hypotension may occur.</p><p>&bull;&nbsp;&nbsp;&nbsp; <strong>Antidiabetic drugs </strong>(oral agents and insulin)&mdash;dosage adjustment of the antidiabetic drug may be required.</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;<strong>Other antihypertensive drugs </strong>additive effect or potentiation.</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;<strong>Cholestyramine and colestipol resins</strong></p><p>Absorption of Hydrochlorothiazide is impaired in the presence of anionic exchange</p><p>resins. Single doses of either cholestyramine or colestipol resins bind the Hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively.</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;<strong>Corticosteroids</strong></p><p>Intensify electrolyte depletion, particularly hypokalemia.</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;<strong>P</strong><strong>r</strong><strong>e</strong><strong>ssor amines (e.g., norepinephrine)</strong></p><p>Possibly decrease response to pressor amines but not sufficient to preclude their use.</p><p>&nbsp;</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;<strong>Sk</strong><strong>e</strong><strong>letal muscle relaxants, nondepolarizing (e.g., tubocurarine)</strong></p><p>Possible increased responsiveness to the muscle relaxant.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;<strong>L</strong><strong>ithium</strong></p><p>Generally, should not be given with diuretics. Diuretic agents reduce the renal clearance of</p><p>lithium and add a high risk of lithium toxicity.</p><p>&nbsp;</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;<strong>Non-steroidal Anti-inflammatory Drugs</strong></p><p>In some patients, the administration of a non-steroidal anti-inflammatory agent can</p><p>reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when Hydrochlorothiazide and non-steroidal anti- inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.</p><p>&nbsp;</p><p><strong>D</strong><strong>rug/Laboratory Test Interactions</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>Hydrochlorothiazide should be discontinued before carrying out tests for parathyroid function (see Section 4-4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>P</strong><strong>r</strong><strong>e</strong><strong>gnancy Category B</strong></p><p>&nbsp;</p><p>Routine use of diuretics during normal pregnancy is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy and there is no satisfactory evidence that they are useful in the treatment of toxemia.</p><p>Edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. Hydrochlorothiazide are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy (see section 4-4). Dependent edema in pregnancy, resulting from restriction of venous return by the gravid uterus, is properly treated through elevation of the lower extremities and use of support stockings. Use of diuretics to lower intravascular volume in this instance is illogical and unnecessary. During normal pregnancy there is hypervolemia which is not harmful to the fetus or the mother in the absence of cardiovascular disease.</p><p>However, it may be associated with edema, rarely generalized edema. If such edema causes discomfort, increased recumbency will often provide relief. Rarely this edema may cause extreme discomfort which is not relieved by rest. In these instances, a short course of diuretic therapy may provide relief and be appropriate.</p><p>&nbsp;</p><p>Hydrochlorothiazide are excreted in breast milk. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue Hydrochlorothiazide, taking into account the importance of the drug to the mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>MONOZIDE may impair the patient&#39;s reactions, especially at the beginning of treatment, e.g. when driving or using machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;The following adverse reactions have been reported and, within each category, are listed in order of decreasing severity.</p><p>&nbsp;</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Body as a Whole: Weakness.</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Cardiovascular:</p><p>Hypotension including orthostatic hypotension (may be aggravated by alcohol, barbiturates, narcotics or antihypertensive drugs).</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Digestive:</p><p>Pancreatitis, jaundice (intrahepatic cholestatic jaundice), diarrhea, vomiting, sialadenitis, cramping, constipation, gastric irritation, nausea, anorexia.</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Hematologic:</p><p>Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia.</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Hypersensitivity:</p><p>Anaphylactic reactions, necrotizing angiitis (vasculitis and cutaneous vasculitis), respiratory distress including pneumonitis and pulmonary edema, photosensitivity, fever, urticaria, rash, purpura.</p><p>&bull;&nbsp; &nbsp;Metabolic:</p><p>Electrolyte imbalance (see section 4-4), hyperglycemia, glycosuria, hyperuricemia.</p><p>&nbsp;</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Musculoskeletal: Muscle spasm.</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Nervous System/Psychiatric:</p><p>Vertigo, paresthesias, dizziness, headache, restlessness.</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Renal:</p><p>Renal failure, renal dysfunction, interstitial nephritis (see section 4-4).</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Skin:</p><p>Erythema multiforme including Stevens-Johnson syndrome, exfoliative dermatitis including toxic epidermal necrolysis, alopecia.</p><p>&nbsp;</p><p>Non-melanoma Skin Cancer: Hydrochlorothiazide is associated with an increased risk of non-melanoma skin cancer. In a study conducted in the Sentinel System, increased risk was predominantly for squamous cellcarcinoma (SCC) and in white patients taking large cumulative doses. The increased risk for SCC in the overall population was approximately 1 additional case per 16,000 patients per year, and for white patients taking acumulative dose of &ge;50,000mg the risk increase was approximately 1additional SCC case for every 6,700 patients per year.</p><p>&nbsp;</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Special Senses:</p><p>Transient blurred vision, xanthopsia.</p><p>&nbsp;</p><p>&bull;&nbsp; &nbsp;Urogenital: Impotence.</p><p>Whenever adverse reactions are moderate or severe, thiazide dosage should be reduced or therapy withdrawn.</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Eye disorders: choroidal effusion (frequency not known)</p><p>For bendroflumethiazide, cicletanine, clopamide, cyclopenthiazide, hydroflumethiazide, metipamide, metolazone, xipamide-containing products (choroidal effusion has not yet been reported but is considered a class effect): Cases of choroidal effusion with visual field defect have been reported after the use of thiazide and thiazide-like diuretics.</p><p>&nbsp;</p><p>Saudi Arabia: To report any side effect(s): National Pharmacovigilance Center (NPC):&nbsp; Fax: +966-11-205-7662, SFDA Call center: 19999, E-mail: npc.drug@sfda.gov.sa, Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most common signs and symptoms observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, hyponatremia) and dehydration resulting from excessive diuresis. If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias.</p><p>&nbsp;</p><p>In the event of overdosage, symptomatic and supportive measures should be employed. Emesis should be induced or gastric lavage performed. Correct dehydration, electrolyte imbalance, hepatic coma and hypotension by established procedures. If required, give oxygen or artificial respiration for respiratory impairment. The degree to which Hydrochlorothiazide is removed by hemodialysis has not been established</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p><strong>P</strong><strong>harmacotherapeutic group: </strong>Diuretics , Thiazides</p><p>&nbsp;</p><p>ATC code: C03AA03</p><p>Hydrochlorothiazide affects the distal renal tubular mechanism of electrolyte reabsorption. At maximal therapeutic dosage all thiazides are approximately equal in their diuretic efficacy.</p><p>Hydrochlorothiazide increases excretion of sodium and chloride in approximately equivalent amounts. Natriuresis may be accompanied by some loss of potassium and bicarbonate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>&nbsp;</p><p>Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney. When plasma levels have been followed for at least 24 hours, the plasma half-life has been observed to vary between 5.6 and 14.8 hours. At least 61% of the oral dose is eliminated unchanged within 24 hours. Hydrochlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Two-year feeding studies in mice and rats conducted under the auspices of the National Toxicology Program (NTP) uncovered no evidence of a carcinogenic potential of Hydrochlorothiazide in female mice (at doses of up to approximately 600 mg/kg/day) or in male and female rats (at doses of up to approximately 100 mg/kg/day). The NTP, however, found equivocal evidence for hepatocarcinogenicity in male mice.</p><p>&nbsp;</p><p>Hydrochlorothiazide was not genotoxic in vitro in the Ames mutagenicity assay of Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537, and TA 1538 and in the Chinese Hamster Ovary (CHO) test for chromosomal aberrations, or in vivo in assays using mouse germinal cell chromosomes, Chinese hamster bone marrow chromosomes, and the Drosophila sex-linked recessive lethal trait gene. Positive test results were obtained only in the in vitro CHO Sister Chromatid Exchange (clastogenicity) and in the Mouse Lymphoma Cell (mutagenicity) assays, using concentrations of Hydrochlorothiazide from 43 to 1300 mcg/mL, and in the Aspergillus nidulans non- disjunction assay at an unspecified concentration.</p><p>&nbsp;</p><p>Hydrochlorothiazide had no adverse effects on the fertility of mice and rats of either sex in studies wherein these species were exposed, via their diet, to doses of up to</p><p>100 and 4 mg/kg, respectively, prior to conception and throughout gestation.</p><p>&nbsp;</p><p>&nbsp;</p><p>Studies in which Hydrochlorothiazide was orally administered to pregnant mice and rats during their respective periods of major organogenesis at doses up to 3000 and</p><p>1000 mg Hydrochlorothiazide/kg, respectively, provided no evidence of harm to the fetus.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lactose Direct Compression (Ludipress)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pregelatinized maize starch</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purified Talc</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colloidal anhydrous silica</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Magnesium stearate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Three years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&ordm;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MONOZIDE 12.5Tablets are packed in boxes of 30 Tablets blistered in PVC/PE/ PVDC (90) /Aluminum foil blisters.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MONOZIDE 12.5Tablets are packed in boxes of 1000 Tablets blistered in PVC/PE/ PVDC (90) /Aluminum foil blisters.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of accordance with local requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Jordanian Pharmaceutical Manufacturing Co. Ltd. PO Box 151
Um Al-Amad 16197

Jordan

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                September 2023. 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>